Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...
Zacks.com on MSN2d
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?The market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...
Amedisys, Inc. (NASDAQ:AMED – Free Report) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for Amedisys in a note issued to investors on Wednesday, January 29th.
In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...
Amedisys Inc is a provider of home health services to the chronic, co-morbid, aging American population. The company's operations include servicing patients through its segments home health, hospice ...
Amedisys Price Performance NASDAQ AMED opened at $92.61 on Tuesday. The company has a 50 day moving average price of $89.23 and a two-hundred day moving average price of $94.12. Amedisys, Inc. has ...
BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback